These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19362969)

  • 1. High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas.
    Braggio E; Keats JJ; Leleu X; Wier SV; Jimenez-Zepeda VH; Schop RF; Chesi M; Barrett M; Stewart AK; Dogan A; Bergsagel PL; Ghobrial IM; Fonseca R
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):39-42. PubMed ID: 19362969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.
    Braggio E; Keats JJ; Leleu X; Van Wier S; Jimenez-Zepeda VH; Valdez R; Schop RF; Price-Troska T; Henderson K; Sacco A; Azab F; Greipp P; Gertz M; Hayman S; Rajkumar SV; Carpten J; Chesi M; Barrett M; Stewart AK; Dogan A; Bergsagel PL; Ghobrial IM; Fonseca R
    Cancer Res; 2009 Apr; 69(8):3579-88. PubMed ID: 19351844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.
    Braggio E; Dogan A; Keats JJ; Chng WJ; Huang G; Matthews JM; Maurer MJ; Law ME; Bosler DS; Barrett M; Lossos IS; Witzig TE; Fonseca R
    Mod Pathol; 2012 May; 25(5):651-60. PubMed ID: 22301699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic abnormalities of Waldenström macroglobulinemia and related low-grade B-cell lymphomas.
    Braggio E; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):198-201. PubMed ID: 23477936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
    Ocio EM; Hernandez JM; Mateo G; Sanchez ML; Gonzalez B; Vidriales B; Gutierrez NC; Orfao A; San Miguel JF
    Clin Lymphoma; 2005 Mar; 5(4):241-5. PubMed ID: 15794856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isochromosome (6p) in Waldenstrom's macroglobulinemia.
    White AD; Clark RE; Jacobs A
    Cancer Genet Cytogenet; 1992 Jan; 58(1):89-91. PubMed ID: 1728957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal chromosome abnormalities in patients with Waldenström's and CLL-associated macroglobulinemia: significance of trisomy 12.
    Han T; Sadamori N; Takeuchi J; Ozer H; Henderson ES; Bhargava A; Fitzpatrick J; Sandberg AA
    Blood; 1983 Sep; 62(3):525-31. PubMed ID: 6411149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
    Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ
    Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput genomic analysis in Waldenström's macroglobulinemia.
    Poulain S; Braggio E; Roumier C; Aijjou R; Broucqsault N; Galiègue-Zouitina S; Manier S; Soenen V; Nibourel O; Duthilleul P; Fonseca R; Leleu X
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):106-8. PubMed ID: 21454205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma.
    Kim WS; Honma K; Karnan S; Tagawa H; Kim YD; Oh YL; Seto M; Ko YH
    Genes Chromosomes Cancer; 2007 Aug; 46(8):776-83. PubMed ID: 17492759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.
    Nguyen-Khac F; Lambert J; Chapiro E; Grelier A; Mould S; Barin C; Daudignon A; Gachard N; Struski S; Henry C; Penther D; Mossafa H; Andrieux J; Eclache V; Bilhou-Nabera C; Luquet I; Terre C; Baranger L; Mugneret F; Chiesa J; Mozziconacci MJ; Callet-Bauchu E; Veronese L; Blons H; Owen R; Lejeune J; Chevret S; Merle-Beral H; Leblondon V; ; ;
    Haematologica; 2013 Apr; 98(4):649-54. PubMed ID: 23065509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome changes in 19 patients with Waldenström's macroglobulinemia.
    Palka G; Spadano A; Geraci L; Fioritoni G; Dragani A; Calabrese G; Guanciali Franchi P; Stuppia L
    Cancer Genet Cytogenet; 1987 Dec; 29(2):261-9. PubMed ID: 3119188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic factors and pathogenesis of Waldenström's macroglobulinemia.
    Monge J; Braggio E; Ansell SM
    Curr Oncol Rep; 2013 Oct; 15(5):450-6. PubMed ID: 23901022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-banding and molecular cytogenetic analyses of marginal zone lymphoma.
    Aamot HV; Micci F; Holte H; Delabie J; Heim S
    Br J Haematol; 2005 Sep; 130(6):890-901. PubMed ID: 16156859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent updates in the indolent lymphomas: Update on marginal zone lymphoma and Waldenström's macroglobulinemia.
    Amaador K; Thieblemont C; Trotman J; Minnema MC
    Hematol Oncol; 2023 Jul; ():. PubMed ID: 37458281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.
    McMaster ML; Giambarresi T; Vasquez L; Goldstein AM; Tucker MA
    Clin Lymphoma; 2005 Mar; 5(4):230-4. PubMed ID: 15794854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia.
    Panayiotidis P; Tumyan G; Thieblemont C; Ptushkin VV; Marin-Niebla A; García-Sanz R; Le Gouill S; Stathis A; Bottos A; Hamidi H; Katz P; Perretti T; Willis JC; Buske C
    Leuk Lymphoma; 2022 May; 63(5):1058-1069. PubMed ID: 35045765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.
    Callet-Bauchu E; Baseggio L; Felman P; Traverse-Glehen A; Berger F; Morel D; Gazzo S; Poncet C; Thieblemont C; Coiffier B; Magaud JP; Salles G
    Leukemia; 2005 Oct; 19(10):1818-23. PubMed ID: 16094418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex karyotype including 14q+ marker in a case of Waldenström's macroglobulinemia.
    Cigudosa JC; Calasanz MJ; Pérez C; Rifón J; Cuesta B; Gullon A
    Cancer Genet Cytogenet; 1994 Apr; 73(2):169-70. PubMed ID: 8174094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.